Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: A transmission dynamic model-based evaluation
- 21 December 2007
- Vol. 26 (1) , 128-139
- https://doi.org/10.1016/j.vaccine.2007.10.056
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Model for Assessing Human Papillomavirus Vaccination StrategiesEmerging Infectious Diseases, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Emerging Infections: Genital Human Papillomavirus InfectionClinical Infectious Diseases, 2006
- Cost-Effectiveness of Treating Multidrug-Resistant TuberculosisPLoS Medicine, 2006
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Prognostic factors related to cervical cancer survival in Mexican womenInternational Journal of Gynecology & Obstetrics, 2001
- Costo-efectividad de intervenciones para insuficiencia renal crónica terminalRevista de Saúde Pública, 1998
- Papanicolaou smear screening augmented by a magnified chemiluminescent examInternational Journal of Gynecology & Obstetrics, 1993
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993